๐Ÿ•ต๏ธ Regis Corp ($RGS)

SEC insider & ownership activity, last 12 months ยท CIK 716643 ยท every row links its SEC filing

Over the last 12 months insiders sold $14K with no open-market buying against it. Michael J. Merriman sold $14K in discretionary trades (Dec). No red-flag 8-Ks in the window.

Aug 2025: net +$0 Sep 2025: net +$0 Oct 2025: net +$0 Nov 2025: net +$0 Dec 2025: net -$14K Jan 2026: net +$0 Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net +$0 Jun 2026: net +$0 Jul 2026: net +$0
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

0 buyers, $0 (0 lots) ยท 1 seller, $14K (1 lots)

InsiderBuysBoughtSellsSoldLast
Michael J. Merriman0โ€“ 1$14KDec 17, 2025

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Light Mark$49KJan 26, 2026 filing โ†—
Light Mark$5KJan 23, 2026 filing โ†—
Light Mark$1KJan 15, 2026 filing โ†—
Light Mark$3KJan 13, 2026 filing โ†—
Michael J. Merriman$14KDec 17, 2025 filing โ†—
Light Mark$121KNov 26, 2025 filing โ†—
Rhoades M Ann$12KNov 26, 2025 filing โ†—
Rhoades M Ann$37KNov 25, 2025 filing โ†—
Rhoades M Ann$39KNov 21, 2025 filing โ†—
Rhoades M Ann$16KNov 20, 2025 filing โ†—
Rhoades M Ann$100KNov 18, 2025 filing โ†—
Rhoades M Ann$119KNov 17, 2025 filing โ†—
Rhoades M Ann$4KNov 14, 2025 filing โ†—
Doctor Matthew$21KOct 24, 2025 filing โ†—
Doctor Matthew$23KOct 20, 2025 filing โ†—
Doctor Matthew$58KOct 15, 2025 filing โ†—
Doctor Matthew$12KSep 26, 2025 filing โ†—
Doctor Matthew$27KSep 19, 2025 filing โ†—
Doctor Matthew$278KSep 18, 2025 filing โ†—

Material events (8-K)

ItemEvent date
Officer/director changes (5.02)Apr 10, 2026 filing โ†—
Earnings (2.02)Mar 31, 2026 filing โ†—
Financial Statements and Exhibits (9.01)Mar 16, 2026 filing โ†—
Officer/director changes (5.02)Mar 13, 2026 filing โ†—
Earnings (2.02)Dec 31, 2025 filing โ†—
Shareholder vote (5.07)Oct 28, 2025 filing โ†—
Earnings (2.02)Sep 30, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 30, 2025 filing โ†—
Earnings (2.02)Sep 3, 2025 filing โ†—
Financial Statements and Exhibits (9.01)Sep 3, 2025 filing โ†—